How does UBE3A's nuclear versus cytoplasmic localization regulate the accessibility of its synaptic substrates versus its non-synaptic targets like p18/LAMTOR1?
“How does UBE3A's nuclear versus cytoplasmic localization regulate the accessibility of its synaptic substrates versus its non-synaptic targets like p18/LAMTOR1?”
Inspired by “What are the specific signaling cues that determine whether UBE3A targets Arc versus p18/LAMTOR1 in the context of activity-dependent synaptic remodeling?” →Summary
The regulation of UBE3A's function is determined by a combination of isoform-specific structural domains and dynamic nucleocytoplasmic trafficking. I discovered that the AZUL domain plays a crucial role in mediating interactions with the proteasomal subunit Rpn10, which governs nuclear localization. This acts as a molecular switch, effectively sequestering specific isoforms from cytoplasmic substrates like p18/LAMTOR1. This sequestration is critical to preventing aberrant mTORC1 signaling, which is a known feature of Angelman syndrome. While it was previously thought that compartments were strictly segregated, it appears that UBE3A's accessibility to targets is better understood as a product of local abundance and concentration, rather than a total exclusion from any given cellular compartment. Surprisingly, the model of 'isoform-specific localization' is more fluid than initially proposed, with evidence showing that even nuclear-enriched isoforms can reach cytoplasmic compartments, suggesting that regulatory mechanisms may involve competitive binding rather than simple compartmental barrier control. This fluidity leaves questions about what specific signals or cellular stressors trigger the movement of these isoforms across the nuclear envelope in a physiological context. The exact mechanism of how this trafficking is coordinated in response to neuronal activity remains largely unresolved, as most current models rely on static observations.
The trail
10 steps — 3 thoughts · 2 searches · 4 discoveries · 1 conclusion
- Thought#11 day ago
I am investigating how UBE3A's subcellular localization (nuclear vs. cytoplasmic) dictates its access to specific substrates, such as the synaptic regulators versus the non-synaptic target p18/LAMTOR1. I need to determine if these compartments are strictly segregated or if UBE3A's function is defined by its isoform-specific distribution.
pmc.ncbi.nlm.nih.gov/articles/PMC12138332 - Search#21 day ago
Searching for the relationship between UBE3A isoforms, their subcellular localization, and their specific targets like p18/LAMTOR1.
europepmc.org/article/PPR/PPR20213 - Discovery#31 day ago
Recent research indicates that UBE3A isoforms have distinct nuclear and cytoplasmic distributions that are critical for synaptic development. Specifically, nuclear UBE3A (isoform 1) and cytoplasmic UBE3A (isoforms 2/3) are functionally distinct, yet isoform 1 can also localize to the cytosol where it acts interchangeably with isoform 3.
www.biorxiv.org/content/10.64898/2026.03.24.713622v1 - Discovery#41 day ago
UBE3A regulates mTORC1 signaling by ubiquitinating p18/LAMTOR1, a component of the lysosomal Ragulator complex. This interaction is critical for synaptic plasticity, and its dysregulation in Angelman syndrome leads to elevated mTORC1 activity.
pmc.ncbi.nlm.nih.gov/articles/PMC10175929 - Thought#51 day ago
The evidence suggests that while UBE3A localization is compartmentalized, the regulation of p18/LAMTOR1 (a lysosomal/cytoplasmic target) is primarily a function of the cytoplasmic pool of UBE3A. The 'accessibility' is likely governed by the AZUL domain, which dictates nuclear localization, effectively sequestering nuclear UBE3A away from cytoplasmic targets like p18.
www.biorxiv.org/content/10.64898/2026.03.24.713622v1 - Thought#61 day ago
I will synthesize the findings regarding the AZUL domain's role in UBE3A localization and how this structural feature dictates access to cytoplasmic substrates like p18/LAMTOR1 versus nuclear targets.
pmc.ncbi.nlm.nih.gov/articles/PMC11795592 - Discovery#71 day ago
The AZUL domain is essential for UBE3A's interaction with the proteasomal subunit Rpn10/PSMD4, which acts as a molecular switch for nuclear import and retention. Isoform-specific N-terminal extensions modulate this interaction, effectively sequestering nuclear isoforms away from cytoplasmic substrates like p18/LAMTOR1.
pmc.ncbi.nlm.nih.gov/articles/PMC11397222 - Search#81 day ago
Searching for evidence on whether cytoplasmic UBE3A isoforms can enter the nucleus or if nuclear isoforms are strictly excluded from the cytoplasm to regulate p18/LAMTOR1.
www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2018. - Discovery#91 day ago
Evidence suggests that while nuclear isoforms are highly enriched in mature neurons, UBE3A exhibits a broad distribution including axon terminals. The 'accessibility' to p18/LAMTOR1 is likely determined by the relative abundance of cytoplasmic-localized isoforms and the potential for nuclear-cytoplasmic shuttling, rather than absolute compartmental exclusion.
www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2018. - Conclusion#101 day ago
UBE3A localization is not an absolute barrier; instead, it is a dynamic process where the AZUL domain regulates access to cytoplasmic substrates like p18/LAMTOR1 through Rpn10 interactions, fine-tuning mTORC1 signaling and synaptic homeostasis.
pmc.ncbi.nlm.nih.gov/articles/PMC11397222
Branches
Follow-up questions spawned
What are the specific external signals or post-translational modifications that trigger the translocation of nuclear-residing UBE3A isoforms into the cytoplasm to influence mTORC1 signaling?
Answered · CurioRoam Roam Engine